Zacks Research Forecasts Weaker Earnings for Henry Schein

Henry Schein, Inc. (NASDAQ:HSICFree Report) – Research analysts at Zacks Research lowered their Q1 2026 earnings estimates for Henry Schein in a report released on Thursday, October 17th. Zacks Research analyst R. Department now forecasts that the company will earn $1.41 per share for the quarter, down from their prior estimate of $1.42. The consensus estimate for Henry Schein’s current full-year earnings is $4.74 per share.

Other equities analysts also recently issued reports about the stock. UBS Group decreased their price objective on shares of Henry Schein from $75.00 to $72.00 and set a “neutral” rating on the stock in a report on Wednesday, August 7th. JPMorgan Chase & Co. cut their price objective on Henry Schein from $88.00 to $80.00 and set an “overweight” rating for the company in a research note on Monday, August 12th. Baird R W raised Henry Schein from a “hold” rating to a “strong-buy” rating in a research note on Monday, July 22nd. Robert W. Baird reduced their price objective on Henry Schein from $92.00 to $82.00 and set an “outperform” rating for the company in a research note on Wednesday, August 7th. Finally, Evercore ISI upped their target price on shares of Henry Schein from $70.00 to $74.00 and gave the stock an “in-line” rating in a report on Tuesday, October 8th. One research analyst has rated the stock with a sell rating, six have given a hold rating, five have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $77.50.

Check Out Our Latest Stock Report on Henry Schein

Henry Schein Trading Up 1.0 %

Shares of HSIC stock opened at $72.39 on Monday. The stock has a 50 day simple moving average of $70.40 and a 200-day simple moving average of $69.85. Henry Schein has a 1-year low of $60.01 and a 1-year high of $82.63. The company has a market cap of $9.27 billion, a price-to-earnings ratio of 24.46, a PEG ratio of 1.98 and a beta of 0.86. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.55 and a quick ratio of 0.90.

Henry Schein (NASDAQ:HSICGet Free Report) last announced its quarterly earnings results on Tuesday, August 6th. The company reported $1.23 earnings per share for the quarter, beating the consensus estimate of $1.22 by $0.01. The firm had revenue of $3.10 billion during the quarter, compared to analyst estimates of $3.27 billion. Henry Schein had a return on equity of 13.19% and a net margin of 2.82%. Henry Schein’s revenue for the quarter was up .0% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.31 EPS.

Hedge Funds Weigh In On Henry Schein

Hedge funds have recently modified their holdings of the business. Empirical Finance LLC boosted its stake in Henry Schein by 3.5% during the first quarter. Empirical Finance LLC now owns 4,764 shares of the company’s stock worth $360,000 after buying an additional 160 shares during the period. Covestor Ltd boosted its position in shares of Henry Schein by 12.8% during the 1st quarter. Covestor Ltd now owns 1,511 shares of the company’s stock worth $114,000 after purchasing an additional 171 shares during the period. Simplify Asset Management Inc. increased its holdings in Henry Schein by 5.0% in the 2nd quarter. Simplify Asset Management Inc. now owns 3,695 shares of the company’s stock valued at $237,000 after purchasing an additional 175 shares during the last quarter. Sequoia Financial Advisors LLC increased its holdings in Henry Schein by 3.2% in the 2nd quarter. Sequoia Financial Advisors LLC now owns 5,680 shares of the company’s stock valued at $364,000 after purchasing an additional 176 shares during the last quarter. Finally, Studio Investment Management LLC raised its position in Henry Schein by 4.7% in the second quarter. Studio Investment Management LLC now owns 4,502 shares of the company’s stock valued at $289,000 after purchasing an additional 204 shares during the period. 96.62% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at Henry Schein

In other news, SVP Lorelei Mcglynn sold 21,035 shares of the firm’s stock in a transaction that occurred on Friday, September 6th. The shares were sold at an average price of $69.30, for a total transaction of $1,457,725.50. Following the completion of the sale, the senior vice president now owns 71,833 shares in the company, valued at $4,978,026.90. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 1.14% of the stock is currently owned by company insiders.

Henry Schein Company Profile

(Get Free Report)

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Further Reading

Earnings History and Estimates for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.